Dietary copper and high saturated and trans fat intakes associated with cognitive decline

Archives of Neurology

Volumn 63, Issue 8, 2006, Pages 1085-1088

  Morris, Martha Clare ^a,b   Evans, Denis A ^a,b   Tangney, Christine C ^b   Bienias, Julia L ^a,b   Schneider, Julie A ^b,c   Wilson, Robert S ^b,c   Scherr, Paul A ^d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; IRON; TRANS FATTY ACID; ZINC;

AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIETARY INTAKE; DISEASE ASSOCIATION; FAT INTAKE; FEMALE; FREQUENCY ANALYSIS; HUMAN; INTERVIEW; IRON INTAKE; MALE; MINI MENTAL STATE EXAMINATION; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; UNITED STATES; VITAMIN SUPPLEMENTATION;

AGED; COGNITION DISORDERS; COPPER; DIET SURVEYS; DIETARY FATS; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; TRANS FATTY ACIDS;

EID: 33747204555     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.8.1085     Document Type: Article

References (21)

1. Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology. 2004;62:1573-1579.
2. Morris MC, Evans DA, Bienias JL, et al. Dietary fats and the risk of incident Alzheimer's disease. Arch Neurol. 2003;60:194-200.
3. Greenwood CE, Winocur G. Cognitive impairment in rats fed high-fat diets: a specific effect of saturated fatty-acid intake. Behav Neurosci. 1996;110:451-459.
4. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb. 1992;12:911-919.
5. Sparks DL, Schreurs BG. Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2003;100:11065-11069.
6. Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann N Y Acad Sci. 2004;1012:153-163.
7. Cherny RA, Atwood CS, Xilinas ME, et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 2001;30:665-676.
8. Curtain CC, Ali F, Volitakis I, et al. Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem. 2001;276:20466-20473.
9. Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer's disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol. 2003;60:185-189.
10. Morris MC, Colditz GA, Evans DA. Response to a mail nutritional survey in an older bi-racial community population. Ann Epidemiol. 1998;8:342-346.
11. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analysis. Am J Epidemiol. 1986;124:17-27.
12. Scherr PA, Albert MS, Funkenstein HH, et al. Correlates of cognitive function in an elderly community population. Am J Epidemiol. 1988;128:1084-1101.
13. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
14. Smith A. Symbol Digit Modalities Test Manual-Revised. Los Angeles, Calif: Western Psychological; 1984.
15. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963-974.
16. Sparks DL, Scheff SW, Hunsaker JC, et al. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol. 1994;126:88-94.
17. Huang X, Cuajungco MP, Atwood CS, et al. Cu(II) potentiation of Alzheimer abeta neurotoxicity: correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem. 1999;274:37111-37116.
18. Squitti R, Rossini PM, Cassetta E, et al. d-Penicillamine reduces serum oxidative stress in Alzheimer's disease patients. Eur J Clin Invest. 2002;32:51-59.
19. Squitti R, Pasqualetti P, Cassetta E, et al. Elevation of serum copper levels discriminates Alzheimer's disease from vascular dementia. Neurology. 2003;60:2013-2014.
20. Smorgon C, Mari E, Atti AR, et al. Trace elements and cognitive impairment: an elderly cohort study. Arch Gerontol Geriatr Suppl. 2004;9:393-402.
21. Squitti R, Lupoi D, Pasqualetti P, et al. Elevation of serum copper levels in Alzheimer's disease. Neurology. 2002;59:1153-1161.